A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by Weill Cornell Medicine. Researchers found that only 1.6% of 546 Ugandan patients had mutations linked to lenacapavir resistance,
Life for Mike Elvis Tusubira, a motorcycle taxi rider with HIV in Uganda, has been turned upside down since US President Donald Trump halted foreign aid last month. Not only does the 35-year-old fear for his own survival as he takes life-saving anti-retroviral (ARV) drugs - but he says he will have to split up from his wife as they can no longer have safe sex.
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
5d
News Medical on MSNNew HIV therapy lenacapavir shows high efficacy in Ugandan populationA multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. The study,
The Trump administration's stop-work order is affecting the HIV response in Uganda, along with malaria and TB programs globally. Plus, a look inside the infamous "Tunnel 12," the source of Rwanda’s Marburg outbreak.
9don MSN
The US aid freeze has critically impacted thousands in Uganda, especially those with HIV, by halting the supply of crucial ARV drugs and preventive medications. This disruption has forced clinics to shut down,
However, certain regions--particularly the Central region, including Kampala--continue to struggle with higher HIV prevalence rates, largely due to urbanization and population density. Uganda has ...
2d
allAfrica.com on MSNUganda: Rukungiri HIV Prevalence Rate At 8.3 PercentThe latest report from the Uganda AIDS Commission has indicated that Rukungiri at 8.3% has the highest HIV prevalence rate in Kigezi sub region.
Waivers were subsequently issued for humanitarian projects, but by that time the HIV programme Mr Tusubira was part of - run out of Marpi Clinic in the north of the capital, Kampala - had closed.
Mike Elvis Tusubira na Ugandan motorcycle taxi rider wey dey live wit HIV since 2022, wen dem first diagnose am.
News Medical on MSN12d
US funding suspension threatens health and research programs in UgandaMalaria vaccination and HIV treatment are among numerous health programmes at risk in Uganda as the country's science research centres suffer the impact of a US freeze on overseas aid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results